Boliden Share Price Deutsche Boerse AG
Stocks
SE0000869646
Specialty Mining & Metals
OTC Markets Traded| Market Cap | 15TCr 1.56TCr 1.34TCr 1.25TCr 1.14TCr 2.15TCr 1,48800Cr 2.19TCr 5.76TCr 75TCr 5.85TCr 5.72TCr 2,46800Cr | P/E 2026 * |
12.5x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 16TCr 1.72TCr 1.47TCr 1.38TCr 1.26TCr 2.37TCr 1,64200Cr 2.41TCr 6.36TCr 82TCr 6.45TCr 6.31TCr 2,72300Cr | EV / Sales 2026 * |
1.4x | EV / Sales 2027 * | 1.24x |
| Free-Float |
98.1% | Yield 2026 * |
2.68% | Yield 2027 * | 3.99% |
Last Transcript: Boliden
| 1 day | -2.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Mikael Staffas
CEO | Chief Executive Officer | 61 | 01/06/2018 |
| Director of Finance/CFO | 59 | 01/04/2016 | |
Linn Andersson
CTO | Chief Tech/Sci/R&D Officer | 48 | 22/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 25/04/2017 | |
| Director/Board Member | 62 | 01/01/2019 | |
| Director/Board Member | 64 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.32% | +5.28% | - | - | 1.54TCr | |
| +3.66% | -0.11% | +114.73% | +170.56% | 16TCr | |
| +4.18% | -0.19% | +66.64% | +78.39% | 9.52TCr | |
| -4.36% | -5.91% | +67.13% | +217.46% | 5.73TCr | |
| +1.03% | -.--% | -.--% | -.--% | 3.18TCr | |
| -6.63% | -7.39% | +219.09% | - | 2.27TCr | |
| -9.30% | -2.92% | +265.73% | +589.89% | 2.46TCr | |
| -2.14% | -5.05% | +85.09% | +197.34% | 2.07TCr | |
| -6.07% | -6.83% | +46.42% | +145.97% | 1.76TCr | |
| -2.99% | -4.65% | +153.35% | +120.01% | 1.66TCr | |
| Average | -2.42% | -3.46% | +113.13% | +189.95% | 4.95TCr | |
| Weighted average by Cap. | +0.63% | -3.35% | +101.16% | +166.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12TCr 1.23TCr 1.05TCr 982.27Cr 901.21Cr 1.69TCr 1,17200Cr 1.72TCr 4.54TCr 59TCr 4.6TCr 4.5TCr 1,94400Cr | 13TCr 1.34TCr 1.15TCr 1.08TCr 987.79Cr 1.86TCr 1,28500Cr 1.89TCr 4.97TCr 64TCr 5.05TCr 4.94TCr 2,13000Cr |
| Net income | 1.16TCr 122.58Cr 105.15Cr 98Cr 90Cr 169.4Cr 12TCr 172.19Cr 453.67Cr 5.88TCr 460.26Cr 450.25Cr 19TCr | 1.4TCr 147.98Cr 126.93Cr 118.53Cr 108.75Cr 204.5Cr 14TCr 207.86Cr 547.66Cr 7.09TCr 555.62Cr 543.53Cr 23TCr |
| Net Debt | 1.52TCr 161.09Cr 138.18Cr 129.03Cr 118.38Cr 222.62Cr 15TCr 226.29Cr 596.2Cr 7.72TCr 604.87Cr 591.71Cr 26TCr | 1.03TCr 109.05Cr 94Cr 87Cr 80Cr 150.71Cr 10TCr 153.19Cr 403.6Cr 5.23TCr 409.47Cr 400.56Cr 17TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
